SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-05-006705
Filing Date
2005-03-16
Accepted
2005-03-16 14:42:31
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2152583z10-k.htm 10-K 903271
2 EXHIBIT 10.3 a2152583zex-10_3.htm EX-10.3 53796
3 EXHIBIT 10.18 a2152583zex-10_18.htm EX-10.18 2720
4 EXHIBIT 10.44 a2152583zex-10_44.htm EX-10.44 2838
5 EXHIBIT 21 a2152583zex-21.htm EX-21 2660
6 EXHIBIT 23.1 a2152583zex-23_1.htm EX-23.1 1954
7 EXHIBIT 31.1 a2152583zex-31_1.htm EX-31.1 5797
8 EXHIBIT 31.2 a2152583zex-31_2.htm EX-31.2 5765
9 EXHIBIT 32.1 a2152583zex-32_1.htm EX-32.1 3224
  Complete submission text file 0001047469-05-006705.txt   984397
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19319 | Film No.: 05684871
SIC: 2834 Pharmaceutical Preparations